Shares of Hims & Hers Health, Inc. ($HIMS) have experienced notable volatility, with a recent decline of 8.7% reported on March 29, 2025. The stock has fluctuated significantly over the past three months, starting near $25, peaking at $70, and currently trading around $30. Trading activity has also been noteworthy, with over $1.2 million in call options sold to open, indicating a potential shift in market sentiment. Additionally, unusual trading patterns have been observed in the biotech sector, particularly with the selling of 3,000 April strangles and the purchase of May strangles. Analysts are closely monitoring these developments as they could signal transformative changes for the company.